Lyme Disease: Lingering Peptidoglycan & Long-Term Effects
Research suggests Lyme's unique peptidoglycan lingers post-treatment, triggering chronic inflammation and long-term effects. Understanding individual immune responses is crucial for better therapies. Long COVID link explored.